BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15207362)

  • 1. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.
    Quelven I; Roussin A; Zajac JM
    Neuroscience; 2004; 126(2):441-9. PubMed ID: 15207362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V; Zajac JM
    Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
    Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM
    Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
    Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
    Quelven I; Roussin A; Zajac JM
    Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice.
    Marchand S; Betourne A; Marty V; Daumas S; Halley H; Lassalle JM; Zajac JM; Frances B
    Peptides; 2006 May; 27(5):964-72. PubMed ID: 16494968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Neuropeptides; 2007 Feb; 41(1):51-8. PubMed ID: 17107711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
    Payza K; Akar CA; Yang HY
    J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide FF, pain and analgesia.
    Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
    Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
    Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain.
    Desprat C; Zajac JM
    Brain Res Dev Brain Res; 1994 Oct; 82(1-2):118-26. PubMed ID: 7842499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
    Mollereau C; Mazarguil H; Zajac JM; Roumy M
    Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D.Tyr1, (NMe)Phe3]NPFF.
    Dupouy V; Zajac JM
    Synapse; 1996 Nov; 24(3):282-96. PubMed ID: 8923669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.
    Roussin A; Serre F; Gouardères C; Mazarguil H; Roumy M; Mollereau C; Zajac JM
    Biochem Biophys Res Commun; 2005 Oct; 336(1):197-203. PubMed ID: 16129413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors.
    Betourne A; Familiades J; Lacassagne L; Halley H; Cazales M; Ducommun B; Lassalle JM; Zajac JM; Frances B
    Neuroscience; 2008 Nov; 157(1):12-21. PubMed ID: 18804517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothermic effects of neuropeptide FF analogues in mice.
    Desprat C; Zajac JM
    Pharmacol Biochem Behav; 1997 Oct; 58(2):559-63. PubMed ID: 9300619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.